Mechanisms of drug-induced lupus: IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo

Arthritis and Rheumatism

Volumn 40, Issue 8, 1997, Pages 1436-1443

  Yung, Raymond ^a,b   Chang, Sandra ^a,b   Hemati, Nahid ^a,b   Johnson, Kent ^a,b   Richardson, Bruce ^a,b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACECAINIDE; HYDRALAZINE; HYDROXYUREA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PHTHALAZINE DERIVATIVE; PROCAINAMIDE;

ADOLESCENT; ADVERSE DRUG REACTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DNA METHYLATION; DRUG EFFECT; DRUG MECHANISM; ETIOLOGY; FEMALE; GENE OVEREXPRESSION; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; AUTOIMMUNITY; DNA METHYLATION; FEMALE; GENE EXPRESSION; HYDRALAZINE; HYDROXYUREA; LUPUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MICE; MICE, INBRED AKR; MICE, INBRED NZB; PROCAINAMIDE; T-LYMPHOCYTES;

EID: 0030985363     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400811     Document Type: Article

References (29)

1. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B: Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 140:2197-2200, 1988
2. Richardson B, Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S: N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide. Arthritis Rheum 31:995-999, 1988
3. Quddus J, Johnson KJ, Gavalchin J, Amento EP, Warren JS, Chrisp C, Yung RL, Richardson BC: Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to induce a lupus-like disease in syngeneic mice. J Clin Invest 92:38-53, 1993
4. Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC: Mechanisms of drug induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 154:3025-3035, 1995
5. Richardson BC, Strahler JR, Pivirotto TS, Quddus J, Bayliss GE, Gross LA, O'Rourke KS, Powers D, Hanash SM, Johnson MA: Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 35:647-662, 1992
6. Richardson B, Powers D, Hooper F, Yung RL, O'Rourke K: Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum 37:1363-1372, 1994
7. Yung R, Powers D, Johnson K, Amento E, Carr D, Laing T, Yang J, Chang S, Hemati N, Richardson B: Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus-like disease in syngeneic recipients. J Clin Invest 97:2866-2871, 1996
8. Kluger J, Drayer DE, Reidenberg MM, Lahita R: Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome. Ann Intern Med 95:18-23, 1981
9. Roden DM, Reele SB, Higgins SB, Wilkinson GR, Smith RF, Oates JA, Woosley RL: Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide. Am J Cardiol 46:463-468, 1980
10. Reidenberg MM: The chemical induction of systemic lupus erythematosus and lupus-like illnesses. Arthritis Rheum 24:1004-1008, 1981
11. Radford IR, Martin RF, Finch L: Effects of hydroxyurea on DNA synthesis in mouse L-cells. Biochim Biophys Acta 696:145-153, 1982
12. Nyce J, Liu L, Jones PA: Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells. Nucleic Acids Res 14:4353-4366, 1986
13. Sanchez-Madrid F, Simon P, Thompson S, Springer TAH: Mapping of antigenic and functional epitopes on the α-and β-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J Exp Med 158:586-602, 1983
14. Richardson B: Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum Immunol 17:456-470, 1986
15. Yung RL, Richardson BC: Drug induced lupus. Rheum Dis Clin North Am 20:61-86, 1994
16. Pals ST, Radaszkiewicz T, Roozendaal L, Gleichmann E: Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction. J Immunol 134:1475-1482, 1985
17. Scheinbart LS, Johnson MA, Gross LA, Edelstein SR, Richardson BC: Procainamide inhibits DNA methyltransferase in a human T cell line. J Rheumatol 18:530-534, 1991
18. Wilson VL, Smith RA, Ma S, Cutler RG: Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem 262:9948-9951, 1987
19. Vanyushin BF, Tkacheva SG, Belozersky AN: Rare bases in animal DNA. Nature 225:948-949, 1970
20. Tissue variation in the overall level of DNA methylation. In, Molecular Biology of DNA Methylation. Edited by RLP Adams, RH Burdon. New York, Springer-Verlag, 1985
21. Golbus J, Palella TD, Richardson BC: Quantitative changes in T cell DNA methylation occur during differentiation and ageing. Eur J Immunol 20:1869-1872, 1990
22. Busslinger M, Hurst J, Flavell RA: DNA methylation and the regulation of globin gene expression. Cell 34:197-206, 1983
23. Gleichmann E, van Elven EH, van der Veen JP: A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12:152-159, 1991
24. Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Reasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549, 1995
25. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M: Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33:1665-1673, 1990
26. Fritzler MJ, Rubin RL: Drug-induced lupus. In, Dubois' Lupus Erythematosus. Fourth edition. Edited by KJ Wallace, BH Hahn. Philadelphia, Lea & Febiger, 1993
27. Rubin RL: Role of xenobiotic oxidative metabolism. Lupus 3:479-482, 1994
28. Dubroff LM, Reid RJ: Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus. Science 208: 404-406, 1980
29. Tomura T, van Lancker JL: Procainamide-DNA interaction. J Rheumatol 15:59-64, 1988